Cited by 21T-cell and Retrovirus StudiesHIV Research and TreatmentVirus-based gene therapy research

A New Role for the HTLV-1 p8 Protein: Increasing Intercellular Conduits and Viral Cell-to-Cell Transmission

Open access
Malbec, Marine, Roesch, Ferdinand, Schwartz, Olivier·2011·Viruses

Abstract

Retroviruses like HIV-1 and HTLV-1 can be transmitted efficiently by direct contact between infected and target cells. For HIV-1, various modes of cell-to-cell transfer have been reported, including virological synapses, polysynapses, filopodial bridges, and nanotube-like structures. So far, only synapses and biofilms have been described for HTLV-1 transmission. Recently, Van Prooyen et al. [1] identified an additional mode of HTLV-1 transmission through cellular conduits induced by the viral accessory protein p8.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/v3030254

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • p8 and Nef both localize at the IS, suppress TCR function, induce conduit/TNT formation, translocate to recipient cells via TNTs, causing cell anergy and viral escape from immune surveillance.

    “Based on HIV and HTLV TNT studies, an analogy can be drawn between the p8 protein from HTLV-1, and Nef from HIV-1. Both proteins localize at the IS, suppress TCR function, and induce conduit/TNT formation. They translocate to recipient cells via TNTs, causing cell anergy and viral escape from immune surveillance [118].”

    From HIV-1 and HTLV-1 Transmission Modes: Mechanisms and Importance for Virus Spread (2022) · cites this paper as [118]

    The Abstract (page not provided) says p8 colocalizes with the immune synapse and down-regulates TCR expression; it also reports that p8 and Nef form intercellular conduits and can transfer to other cells. But it says Nef probably does not induce nanotubes, and describes protection from immune recognition after p8 transfer as a proposed model. It does not establish that transfer by both proteins causes recipient-cell anergy and viral escape. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 21

  1. [1]Van Prooyen N Gold H Andresen V Schwartz O Jones K Ruscetti F Lockett S Gudla P Venzon D Franchini G Human T-cell leukemia virus type 1 p8 protein increases cellular conduits and virus transmission Proc. Natl. Acad. Sci. U. S. A 2010 107 20738 20743 21076035 PMC2996430
  2. [2]Igakura T Stinchcombe JC Goon PK Taylor GP Weber JN Griffiths GM Tanaka Y Osame M Bangham CR Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton Science 2003 299 1713 1716 12589003
  3. [3]Bangham CR The immune control and cell-to-cell spread of human T-lymphotropic virus type 1 J. Gen. Virol 2003 84 3177 3189 14645900
  4. [4]Fukumoto R Andresen V Bialuk I Cecchinato V Walser JC Valeri VW Nauroth JM Gessain A Nicot C Franchini G In vivo genetic mutations define predominant functions of the human T-cell leukemia/lymphoma virus p12I protein Blood 2009 113 3726 3734 18791162 PMC2670790
  5. [5]Taylor JM Brown M Nejmeddine M Kim KJ Ratner L Lairmore M Nicot C Novel role for interleukin-2 receptor-Jak signaling in retrovirus transmission J. Virol 2009 83 11467 11476 19726513 PMC2772716
  6. [6]Pais-Correia AM Sachse M Guadagnini S Robbiati V Lasserre R Gessain A Gout O Alcover A Thoulouze MI Biofilm-like extracellular viral assemblies mediate HTLV-1 cell-to-cell transmission at virological synapses Nat. Med 2010 16 83 89 20023636
  7. [7]Miller MD Warmerdam MT Gaston I Greene WC Feinberg MB The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages J. Exp. Med 1994 179 101 113 8270859 PMC2191317
  8. [8]Albrecht B Collins ND Burniston MT Nisbet JW Ratner L Green PL Lairmore MD Human T-lymphotropic virus type 1 open reading frame I p12(I) is required for efficient viral infectivity in primary lymphocytes J. Virol 2000 74 9828 9835 11024109 PMC102019
  9. [9]Kestler HW 3rd Ringler DJ Mori K Panicali DL Sehgal PK Daniel MD Desrosiers RC Importance of the nef gene for maintenance of high virus loads and for development of AIDS Cell 1991 65 651 662 2032289
  10. [10]Valeri VW Hryniewicz A Andresen V Jones K Fenizia C Bialuk I Chung HK Fukumoto R Parks RW Ferrari MG Nicot C Cecchinato V Ruscetti F Franchini G Requirement of the human T-cell leukemia virus p12 and p30 products for infectivity of human dendritic cells and macaques but not rabbits Blood 2010 116 3809 3817 20647569 PMC2981536
  11. [11]Thoulouze MI Sol-Foulon N Blanchet F Dautry-Varsat A Schwartz O Alcover A Human immunodeficiency virus type-1 infection impairs the formation of the immunological synapse Immunity 2006 24 547 561 16713973
  12. [12]Fukumoto R Dundr M Nicot C Adams A Valeri VW Samelson LE Franchini G Inhibition of T-cell receptor signal transduction and viral expression by the linker for activation of T cells-interacting p12(I) protein of human T-cell leukemia/lymphoma virus type 1 J. Virol 2007 81 9088 9099 17582004 PMC1951423
  13. [13]Schwartz O Marechal V Le Gall S Lemonnier F Heard JM Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein Nat. Med 1996 2 338 342 8612235
  14. [14]Johnson JM Nicot C Fullen J Ciminale V Casareto L Mulloy JC Jacobson S Franchini G Free major histocompatibility complex class I heavy chain is preferentially targeted for degradation by human T-cell leukemia/lymphotropic virus type 1 p12(I) protein J. Virol 2001 75 6086 6094 11390610 PMC114324
  15. [15]Schibeci SD Clegg AO Biti RA Sagawa K Stewart GJ Williamson P HIV-Nef enhances interleukin-2 production and phosphatidylinositol 3-kinase activity in a human T cell line AIDS 2000 14 1701 1707 10985305
  16. [16]Ding W Kim SJ Nair AM Michael B Boris-Lawrie K Tripp A Feuer G Lairmore MD Human T-cell lymphotropic virus type 1 p12I enhances interleukin-2 production during T-cell activation J. Virol 2003 77 11027 11039 14512551 PMC225008
  17. [17]Haller C Tibroni N Rudolph JM Grosse R Fackler OT Nef does not inhibit F-actin remodelling and HIV-1 cell-cell transmission at the T lymphocyte virological synapse Eur. J. Cell Biol 2010 21044805
  18. [18]Nobile C Rudnicka D Hasan M Aulner N Porrot F Machu C Renaud O Prevost M-C Hivroz C Schwartz O Sol-Foulon N HIV-1 Nef Inhibits Ruffles, Induces Filopodia, and Modulates Migration of Infected Lymphocytes J. Virol 2010 84 2282 2293 20015995 PMC2820911
  19. [19]Schwartz O Riviere Y Heard JM Danos O Reduced cell surface expression of processed human immunodeficiency virus type 1 envelope glycoprotein in the presence of Nef J. Virol 1993 67 3274 3280 8497051 PMC237668
  20. [20]Banerjee P Feuer G Barker E Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells J. Virol 2007 81 9707 9717 17609265 PMC2045425
  21. [21]Kim SJ Nair AM Fernandez S Mathes L Lairmore MD Enhancement of LFA-1-mediated T cell adhesion by human T lymphotropic virus type 1 p12I1 J. Immunol 2006 176 5463 5470 16622014 PMC2668115

Cited by

Sorted by citations

Authors
Malbec, M., Roesch, F., & Schwartz, O.
Affiliations
Centre National de la Recherche Scientifique (FR)
Corresponding author
Schwartz, Olivier
Venue
Viruses
Publisher
MDPI AG
Published
2011-03-09
Volume
3
Issue
3
Pages
254-259
ISSN
1999-4915 (ISSN-L)
OpenAlex
W1980633901
Cited by
21
References
2
Citations by year
2024: 4 · 2022: 3 · 2021: 2 · 2020: 3 · 2017: 2 · 2016: 3 · 2015: 1 · 2014: 2
FWCI
0.43
Type
journal article
Language
en
Open access
Locations
  • Viruses (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
Keywords
HTLV-1, p8 protein, virological synapse, nanotubes, filopodia, viral accessory proteins
MeSH terms
Cell Line, Humans, Human T-lymphotropic virus 1, HTLV-I Infections, Viral Regulatory and Accessory Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review